Staging of colorectal cancer using serum metabolomics with 1HNMR Spectroscopy

Authors

  • Ayda Iravani Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
  • Farideh Vahabi Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
  • Fatemeh Mirkhani Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
  • Mohammad Arjmand Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
  • Parastou Bayat Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
  • Reza Hajhosseini Payam Noor University, Tehran, Iran
  • Zahra Zamani Biochemistry Department, Pasteur Institute of Iran, Pasteur Avenue, Tehran, Iran
Abstract:

Objective(s): Determination of stages of colon cancer is done by biopsy usually after surgery. Metabolomics is the study of all the metabolites using LC-MS and 1HNMR spectroscopy with chemometric techniques. The stages of colon cancer were detected from patients' sera using 1HNMR. Materials and Methods: Five ml blood was collected from 16 confirmed patients referred for colonoscopy.  One group of eight patients were diagnosed with stage 0 to I colon cancer and the second group of 8 patients with II-IV stage colon cancer.  Sera were sent for 1HNMR. The differentiating metabolites were identified using HMDB  and the metabolic cycles from Metaboanalyst. Results: Six metabolites of which pyridoxine levels lowered, and glycine, cholesterol, taurocholic acid, cholesteryl ester and deoxyinosine increased. Conclusion: The different stages of cancer were identified by the main metabolic cycles such as primary bile acid biosynthesis, purine and vitamin B metabolic pathways and the glutathione cycle.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Staging of colorectal cancer.

Colorectal carcinoma remains one of the leading causes of cancer death in the United States and worldwide. In fact, the approximate average lifetime risk of colorectal cancer is a staggering 6%. For this reason, it is important that all radiology and nuclear medicine specialists are familiar with and understand how colorectal carcinoma is accurately staged and the role and benefits of PET/CT in...

full text

A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer

BACKGROUND To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer. METHODOLOGY/PRINCIPAL FINDINGS We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-based serum metabolomic analytical method was evaluated by calculating the...

full text

Staging Colorectal Cancer

Although colorectal cancer is often considered as a single entity, initial management and staging of colorectal cancers differ depending on whether the primary tumor is located in the rectum or the colon. The rectum is short (approximately 15 cm) and very close to other structures, with only a narrow margin of fat between the rectal wall and the mesorectal fascia. In addition, unlike the colon,...

full text

Screening & staging of colorectal cancer

In Europe, colorectal cancer (CRC) is the second most common cancer, and the second most common cause of death from cancer [1]. The vast majority of CRC develop from benign precursor lesions, so-called adenomatous polyps, which via the adenoma-carcinoma pathway may eventually transform into colon cancer. It has been shown that endoscopic removal of adenomas interrupts this pathway and subsequen...

full text

Pretreatment Staging of Colorectal Cancer

ACR Appropriateness Criteria 1 Pretreatment Staging Colorectal Cancer American College of Radiology ACR Appropriateness Criteria Clinical Condition: Pretreatment Staging of Colorectal Cancer Variant 1: Rectal cancer (small or superficial). Radiologic Procedure Rating Comments RRL* US pelvis endorectal 8 For assessment of level of rectal wall involvement. O CT chest abdomen pelvis with contrast ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 20  issue 7

pages  835- 840

publication date 2017-07-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023